Search - tctmd.com

Displaying 121 - 140 of 1083

Sort: Relevancy | Date

News Daily News

AHA Statement Stresses Importance of Telehealth in CVD Care

Yael L. Maxwell

November 16, 2022

News Conference News VIVA 2022

‘Heartless’ Indifference Drives PAD/CLTI Amputations in Underserved Groups

L.A. McKeown

November 04, 2022

News Conference News VIVA 2022

TRANSCEND: Low-Dose DCB for PAD Still Looking Good at 2 Years

L.A. McKeown

November 03, 2022

News Conference News AHA 2022

Atrial Fibrosis Mediated by Gum Disease May Be Missing AF Link

L.A. McKeown

November 01, 2022

News Conference News TCT 2022

Pulmonary Artery Denervation in Idiopathic PAH Ups 6-Minute Walk Test

Shelley Wood

September 18, 2022

News Daily News

FDA Approves Pascal TEER Device for Degenerative MR

Shelley Wood

September 15, 2022

News Daily News

Exercise Keeps Athletic Heart Supple, Strong, Healthy: JACC Deep Dive

Michael O'Riordan

September 09, 2022

News Opinion CV Team Dispatch

September 2022 News Roundup

L.A. McKeown

September 01, 2022

News Conference News ESC 2022

DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark

L.A. McKeown

August 30, 2022

News Conference News ESC 2022

First Cardio-Oncology Guidelines From ESC Cover ‘Tremendous’ Territory

L.A. McKeown

August 26, 2022

News Daily News

Worse Complications After PVI in Women Highlight Research Gaps

L.A. McKeown

August 16, 2022

News Daily News

IVUS Useful in Many Peripheral Intervention Scenarios, Consensus Document

L.A. McKeown

August 05, 2022

News Daily News

Meat Consumption and Gut Microbiome Linked to ASCVD Risk

Yael L. Maxwell

August 03, 2022

News Daily News

High Lp(a) May Predict Risk of CV and Limb Events in PAD

L.A. McKeown

July 18, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for June 2022

Caitlin E. Cox

July 04, 2022

News Daily News

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

L.A. McKeown

June 29, 2022

News Daily News

Comorbidities May Drive PAD Procedural Outcomes in Black Patients

L.A. McKeown

June 23, 2022

News Daily News

Five-Year Paclitaxel DCB Data Attest to Long-term Safety, Efficacy

L.A. McKeown

June 01, 2022

News Conference News EAS 2022

Stepwise or Hammer Down? Experts Debate Best Approach to LDL-Lowering

Michael O'Riordan

May 24, 2022

News Conference News SCAI 2022

DISRUPT PAD III: Lithotripsy Prep Linked to Better PAD Patency at 1 Year

L.A. McKeown

May 23, 2022

Advertisement

AHA Statement Stresses Importance of Telehealth in CVD Care

‘Heartless’ Indifference Drives PAD/CLTI Amputations in Underserved Groups

TRANSCEND: Low-Dose DCB for PAD Still Looking Good at 2 Years

Atrial Fibrosis Mediated by Gum Disease May Be Missing AF Link

Pulmonary Artery Denervation in Idiopathic PAH Ups 6-Minute Walk Test

FDA Approves Pascal TEER Device for Degenerative MR

Exercise Keeps Athletic Heart Supple, Strong, Healthy: JACC Deep Dive

September 2022 News Roundup

DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark

First Cardio-Oncology Guidelines From ESC Cover ‘Tremendous’ Territory

Worse Complications After PVI in Women Highlight Research Gaps

IVUS Useful in Many Peripheral Intervention Scenarios, Consensus Document

Meat Consumption and Gut Microbiome Linked to ASCVD Risk

High Lp(a) May Predict Risk of CV and Limb Events in PAD

TCTMD’s Top 10 Most Popular Stories for June 2022

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

Comorbidities May Drive PAD Procedural Outcomes in Black Patients

Five-Year Paclitaxel DCB Data Attest to Long-term Safety, Efficacy

Stepwise or Hammer Down? Experts Debate Best Approach to LDL-Lowering

DISRUPT PAD III: Lithotripsy Prep Linked to Better PAD Patency at 1 Year

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content